Multiple gestations, medications that affect insulin and glucose levels, hypertension or concomitant systemic disease, pre‐gestational known diabetes (type 1–2) or glucose intolerance and FPG levels ≥126 mg/dl. Four women were excluded as lost to follow‐up. The gene discussed is INS; the disease is Glucose intolerance.